Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 2

Status

Completed 2Withdrawn 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 9Genitourinary 3Other neoplasm 1

Conditions

Prostatic Neoplasms 2Fractures, Bone 2Prostatic Intraepithelial Neoplasia 1Precancerous Conditions 1Osteoporosis 1Neoplasms 1Bone Diseases, Metabolic 1

Interventions

Docetaxel 77Radiotherapy 73Prednisone 66Leuprolide 51Goserelin 49Gemcitabine 49Cisplatin 48bicalutamide 46enzalutamide 43Androgen Antagonists 36pembrolizumab 32Abiraterone Acetate 31Mitomycin 29acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 28Magnetic Resonance Spectroscopy 28Carboplatin 27Flutamide 25Nivolumab 24Triptorelin Pamoate 23Sunitinib 23apalutamide 22Radiation 22Doxorubicin 20darolutamide 19abiraterone 18Gonadotropin-Releasing Hormone 18cabozantinib 17atezolizumab 16Specimen Handling 16Radiosurgery 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Toremifene × Genitourinary × Clear all
NCT00106691 2023-06-12

Prostate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia)

GTx

Phase 3 Completed
1,589 enrolled 16 charts
GenitourinaryOther neoplasm

Neoplasms, Precancerous Conditions, Prostatic Intraepithelial Neoplasia

NCT00129142 2013-11-15

Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy

GTx

Phase 3 Completed
1,200 enrolled
Genitourinary

Bone Diseases, Metabolic, Osteoporosis, Prostatic Neoplasms, Fractures, Bone

NCT01214291 2013-11-15

TREAT2

GTx

Phase 3 Withdrawn
Genitourinary

Prostatic Neoplasms, Fractures, Bone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡